UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $620

Benzinga · 1d ago
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers the price target from $640 to $620.